Merck & Co. Inc. (MRK)

Merck & Co. Inc., adjusted current assets

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current assets
	Adjustments
	Add: Allowance for doubtful accounts
	Add: LIFO reserve1
	Less: Current deferred income tax assets (included in Deferred income taxes and other current assets)2
	After Adjustment
	Adjusted current assets

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).

Merck & Co. Inc., adjusted total assets

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total assets
	Adjustments
	Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
	Add: Allowance for doubtful accounts
	Add: LIFO reserve2
	Less: Current deferred income tax assets (included in Deferred income taxes and other current assets)3
	Less: Noncurrent deferred income tax assets (included in Other assets)4
	After Adjustment
	Adjusted total assets

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).

Merck & Co. Inc., adjusted current liabilities

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current liabilities
	Adjustments
	Less: Current deferred income tax liabilities (included in Income taxes payable)1
	After Adjustment
	Adjusted current liabilities

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).

Merck & Co. Inc., adjusted total liabilities

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total liabilities
	Adjustments
	Add: Operating lease liability (before adoption of FASB Topic 842)1
	Less: Current deferred income tax liabilities (included in Income taxes payable)2
	Less: Noncurrent deferred income tax liabilities3
	Less: Restructuring reserves
	After Adjustment
	Adjusted total liabilities

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).

Merck & Co. Inc., adjusted total Merck & Co., Inc. stockholders’ equity

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total Merck & Co., Inc. stockholders’ equity
	Adjustments
	Less: Net deferred income taxes1
	Add: Allowance for doubtful accounts
	Add: LIFO reserve2
	Add: Restructuring reserves
	Add: Noncontrolling interests
	After Adjustment
	Adjusted total Merck & Co., Inc. stockholders’ equity

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).

Merck & Co. Inc., adjusted capitalization table

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Loans payable and current portion of long-term debt
	Long-term debt, excluding current portion
	Total reported debt
	Total Merck & Co., Inc. stockholders’ equity
	Total reported capital
	Adjustments to Debt
	Add: Operating lease liability (before adoption of FASB Topic 842)1
	Adjusted total debt
	Adjustments to Equity
	Less: Net deferred income taxes2
	Add: Allowance for doubtful accounts
	Add: LIFO reserve3
	Add: Restructuring reserves
	Add: Noncontrolling interests
	Adjusted total Merck & Co., Inc. stockholders’ equity
	After Adjustment
	Adjusted total capital

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).

Merck & Co. Inc., adjusted net income attributable to Merck & Co., Inc.

US$ in millions

	12 months ended	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Net income attributable to Merck & Co., Inc.
	Adjustments
	Add: Deferred income tax expense (benefit)1
	Add: Increase (decrease) in allowance for doubtful accounts
	Add: Increase (decrease) in LIFO reserve2
	Add: Increase (decrease) in restructuring reserves
	Add: Other comprehensive income (loss) net of taxes
	Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest
	After Adjustment
	Adjusted net income attributable to Merck & Co., Inc.

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27).